50.13
Inspire Medical Systems Inc stock is traded at $50.13, with a volume of 757.95K.
It is down -0.63% in the last 24 hours and down -22.29% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$50.45
Open:
$50.1
24h Volume:
757.95K
Relative Volume:
0.62
Market Cap:
$1.44B
Revenue:
$911.98M
Net Income/Loss:
$145.42M
P/E Ratio:
10.10
EPS:
4.9642
Net Cash Flow:
$78.48M
1W Performance:
-6.68%
1M Performance:
-22.29%
6M Performance:
-35.10%
1Y Performance:
-68.85%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
50.13 | 1.44B | 911.98M | 145.42M | 78.48M | 4.9642 |
|
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Trend Review: Can Inspire Medical Systems Inc deliver consistent EPS growthPortfolio Return Report & High Conviction Investment Ideas - baoquankhu1.vn
Growth Value: Is Inspire Medical Systems Inc stock influenced by commodity prices2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn
Inspire Medical Systems Hits New 52-Week Low at $50.00 - Markets Mojo
FDA Approves Expanded MRI Compatibility for Inspire IV and V - Sleep Review
Vanguard parent reports 0% in Inspire Medical (INSP) after realignment - Stock Titan
Aug Movers: Does Inspire Medical Systems Inc offer margin of safety2026 Stock Rankings & Proven Capital Preservation Methods - baoquankhu1.vn
These 9 Oversold Stocks Are Significantly Undervalued - Investing.com
Inspire Medical Systems Hits New 52-Week Low at $50.67 - Markets Mojo
Assenagon Asset Management S.A. Invests $24.44 Million in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical wins expanded MRI indications from FDA - MassDevice
Why is Inspire (INSP) down 2.4% since last earnings report? - MSN
Zacks Research Upgrades Inspire Medical Systems (NYSE:INSP) to Strong-Buy - MarketBeat
Inspire Medical Systems Hits 52-Week Low at $51.59 Amid Market Struggles - Markets Mojo
Inspire (INSP) Raised to Strong Buy: Key Information You Need - Bitget
Inspire (INSP) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Inspire Medical Systems stock hits 52-week low at $52.68 By Investing.com - Investing.com Australia
Inspire Medical Systems (NYSE:INSP) Reaches New 1-Year LowTime to Sell? - MarketBeat
Inspire Medical Systems stock hits 52-week low at $52.68 - Investing.com
Wolfe Research downgrades Inspire Medical Systems (INSP) - MSN
Form DEF 14A Inspire Medical Systems For: 20 March By Investing.com - Investing.com
Inspire Medical Systems, Inc. ($INSP) CEO 2025 Pay Revealed - Quiver Quantitative
Inspire Medical surges after KeyBanc sees CMS adding codes for Inspire V implant - MSN
Board changes and equity plan in Inspire Medical Systems (INSP) 2026 proxy - Stock Titan
Form DEFA14A Inspire Medical Systems, - StreetInsider
[ARS] Inspire Medical Systems, In... | INSP SEC FilingForm ARS - Stock Titan
Top 3 Health Care Stocks That Are Set To Fly In March - Benzinga
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Understanding the Setup: (INSP) and Scalable Risk - Stock Traders Daily
Inspire Medical Systems Inc (INSP) Trading 4.94% Higher on Mar 1 - GuruFocus
Inspire Medical Systems (INSP) price target increased by 12.39% to 128.11 - MSN
Inspire Medical Systems (NYSE:INSP) Trading 4.9% HigherHere's Why - MarketBeat
Inspire Medical at 2026 KeyBanc Forum: Navigating Challenges and Growth By Investing.com - Investing.com Canada
Inspire Medical Systems (NYSE:INSP) Shares Down 5.9%Should You Sell? - MarketBeat
INSP: Inspire V’s launch, reimbursement clarity, and innovation drive growth amid evolving competition - TradingView
INSP: Reimbursement updates and Inspire V innovation drive growth amid evolving competition - TradingView
Weekly Earnings: Is Inspire Medical Systems Inc benefiting from interest rate changesPortfolio Value Summary & Weekly Top Performers Watchlists - baoquankhu1.vn
A Look At Inspire Medical Systems (INSP) Valuation After Mixed Q4 Earnings Beat And Reduced 2026 Revenue Guidance - Yahoo Finance
Inspire Medical (INSP): Positive Developments in Sleep Apnea Tre - GuruFocus
Inspire Medical (INSP) Keeps Reimbursement Steady Amid Code Chan - GuruFocus
Bamco Inc. NY Reduces Inspire Medical Systems Stock Holdings - National Today
Bamco Inc. NY Has $14.10 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Braidwell LP Has $65.57 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems, Inc. (NYSE:INSP) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Integral Health Asset Management LLC Boosts Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Why Is Inspire (INSP) Down 2.4% Since Last Earnings Report? - Yahoo Finance
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):